BNP Paribas Financial Markets’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.6K | Buy |
15,437
+11,889
| +335% | +$37.5K | ﹤0.01% | 3453 |
|
|
2025
Q1 | $11.1K | Sell |
3,548
-2,185
| -38% | -$6.86K | ﹤0.01% | 3858 |
|
|
2024
Q4 | $24.9K | Buy |
+5,733
| New | +$24.9K | ﹤0.01% | 3823 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | -$2 | – | 3759 |
|
|
2019
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 3856 |
|
|
2019
Q2 | $2 | Buy |
+1
| New | +$2 | ﹤0.01% | 3900 |
|
|
2019
Q1 | – | Hold |
0
| – | -$1 | – | 3691 |
|
|
2018
Q4 | – | Hold |
0
| – | -$2 | – | 3638 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3762 |
|
|
2018
Q2 | – | Hold |
0
| – | -$7 | – | 3769 |
|
|
2018
Q1 | – | Hold |
0
| – | -$6 | – | 3610 |
|
|
2017
Q4 | – | Hold |
0
| – | -$15 | – | 3527 |
|
|
2017
Q3 | – | Hold |
0
| – | -$26 | – | 3531 |
|
|
2017
Q2 | – | Sell |
-2
| Closed | -$145 | – | 3552 |
|
|
2017
Q1 | $145 | Sell |
2
-19
| -90% | -$1.38K | ﹤0.01% | 3379 |
|
|
2016
Q4 | $3.15K | Sell |
21
-5
| -19% | -$750 | ﹤0.01% | 3218 |
|
|
2016
Q3 | $8.48K | Buy |
26
+5
| +24% | +$1.63K | ﹤0.01% | 3251 |
|
|
2016
Q2 | $6.7K | Buy |
+21
| New | +$6.7K | ﹤0.01% | 3117 |
|
|
2016
Q1 | – | Sell |
-105
| Closed | -$40.7K | – | 2752 |
|
|
2015
Q4 | $40.7K | Buy |
105
+9
| +9% | +$3.49K | ﹤0.01% | 2953 |
|
|
2015
Q3 | $39.3K | Buy |
96
+68
| +243% | +$27.8K | ﹤0.01% | 3033 |
|
|
2015
Q2 | $20.6K | Buy |
+28
| New | +$20.6K | ﹤0.01% | 3036 |
|
|
2014
Q3 | – | Sell |
-8
| Closed | -$2.03K | – | 3562 |
|
|
2014
Q2 | $2.03K | Hold |
8
| – | – | ﹤0.01% | 2616 |
|
|
2014
Q1 | $3.27K | Hold |
8
| – | – | ﹤0.01% | 2091 |
|
|
2013
Q4 | $3.33K | Buy |
+8
| New | +$3.33K | ﹤0.01% | 2853 |
|